The Inside Story On How Bayer Swooped On NASDAQ-Bound Vividion

Paying $1.5bn Upfront To Buy Chemoproteomics Specialist

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.